A NEIL1 single nucleotide polymorphism (rs4462560) predicts the risk of radiation‐induced toxicities in esophageal cancer patients treated with definitive radiotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|23|4205-4211

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.23, 2013-12, pp. : 4205-4211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Definitive radiotherapy for cervical esophageal cancer

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 2, 2015-02 ,pp. : 151-155

John Wiley & Sons Inc

Access to resources Recommend Favorite

Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal Cancer

By  

Visceral Medicine: gastrointestinal medicine and surgery, Vol. 31, Iss. 5, 2015-0 ,pp. : 347-353

Karger

Access to resources Recommend Favorite

MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 78, Iss. 1, 2008-09 ,pp. : 49-55

Karger

Access to resources Recommend Favorite

Outcome reporting in esophageal cancer trials

By  

DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol. 28, Iss. 2, 2015-02 ,pp. : 156-163

John Wiley & Sons Inc

Access to resources Recommend Favorite

An ERCC4 regulatory variant predicts grade‐3 or ‐4 toxicities in patients with advanced non‐small cell lung cancer treated by platinum‐based therapy

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 6, 2018-03 ,pp. : 1218-1229

John Wiley & Sons Inc

Access to resources Recommend Favorite